![](/img/cover-not-exists.png)
A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C
Antonio Ojea, José Luís Nogueira, Eduardo Solsona, Nicolás Flores, Jesús María Fernández Gómez, Jesús Rodríguez Molina, Venancio Chantada, José Emilio Camacho, Luís Martínez Piñeiro, Rafael HernandezVolume:
52
Year:
2007
Language:
english
Pages:
9
DOI:
10.1016/j.eururo.2007.04.062
File:
PDF, 250 KB
english, 2007